参考文献
[1] Rivera-Lebron B, McDaniel M, Ahrar K, et al. Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the pert consortium[J]. Clin Appl Thromb Hemost,2019,25:1076029619853037. DOI: 10.1177/1076029619853037.
[2] Wendelboe AM, McCumber M, Hylek EM, et al. Global public awareness of venous thromboembolism[J]. J Thromb Haemost, 2015,13(8):1365-1371. DOI: 10.1111/jth.13031.
[3] Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (multicenter emergency medicine pulmonary embolism in the real world registry)[J]. J Am Coll Cardiol, 2011,57(6):700-706. DOI: 10.1016/j.jacc.2010.05.071.
[4] Giri J, Sista AK, Weinberg I, et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association[J]. Circulation,2019,140(20):e774- e801.DOI: 10.1161/CIR.0000000000000707.
[5] Pauley E, Orgel R, Rossi JS, et al. Age-stratified national trends in pulmonary embolism admissions[J]. Chest, 2019,156(4):733-742. DOI: 10.1016/j.chest.2019.05.021.
[6] Kempny A, McCabe C, Dimopoulos K, et al. Incidence, mortality and bleeding rates associated with pulmonary embolism in England between 1997 and 2015[J]. Int J Cardiol, 2019,277:229-234. DOI: 10.1016/j.ijcard.2018.10.001.
[7] Zhang Z, Lei J, Shao X, et al. Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China[J]. Chest,2019,155(2):342-353. DOI: 10.1016/j.chest.2018.10.040.
[8] Barco S, Mahmoudpour SH, Valerio L, et al. Trends in mortality related to pulmonary embolism in the European region, 2000-15: analysis of vital registration data from the WHO mortality database[J]. Lancet Respir Med,2020,8(3):277-287. DOI: 10.1016/S2213-2600(19)30354-6.
[9] Zhang M, Zhang YX, Zhang Z, et al. Awareness and management of pulmonary embolism among physicians in China: a nationwide cross-sectional study[J]. J Thromb Thrombolysis, 2019,47(3):436-443. DOI: 10.1007/s11239-018-1788-x.
[10] Kearon C, de Wit K, Parpia S, et al. Diagnosis of pulmonary embolism with D-dimer adjusted to clinical probability[J]. N Engl J Med, 2019,381(22):2125-2134. DOI: 10.1056/NEJMoa1909159.
[11] van der Pol LM, Tromeur C, Bistervels IM, et al. Pregnancyadapted YEARS algorithm for diagnosis of suspected pulmonary embolism[J]. N Engl J Med, 2019,380(12):1139-1149. DOI: 10.1056/NEJMoa1813865.
[12] Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)[J]. Eur Heart J,2020,41(4):543-603. DOI: 10.1093/eurheartj/ehz405. PMID: 31504429.
[13] van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study[J]. Lancet, 2017,390(10091):289-297. DOI: 10.1016/S0140-6736(17)30885-1.
[14] Nagel SN, Steffen IG, Schwartz S, et al. Age-dependent diagnostic accuracy of clinical scoring systems and D-dimer levels in the diagnosis of pulmonary embolism with computed tomography pulmonary angiography (CTPA)[J]. Eur Radiol, 2019,29(9):4563-4571. DOI: 10.1007/s00330-019-06039-5.
[15] Dudzinski DM, Giri J, Rosenfield K. Interventional treatment of pulmonary embolism[J]. Circ Cardiovasc Interv, 2017,10(2):e004345.DOI: 10.1161/CIRCINTERVENTIONS. 116.004345.
[16] Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism[J]. N Engl J Med, 2009,361(24):2342-2352. DOI: 10.1056/NEJMoa0906598.
[17] EINSTEIN Investigators, Bauersachs R, Berkowitz SD, et al. Oral rivaroxaban for symptomatic venous thromboembolism[J]. N Engl J Med, 2010,363(26):2499-2510. DOI: 10.1056/NEJMoa1007903.
[18] Hokusai-VTE Investigators, Büller HR, Décousus H, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism[J]. N Engl J Med,2013,369(15):1406-1415. DOI: 10.1056/NEJMoa1306638.
[19] Agnelli G, Becattini C, Bauersachs R, et al. Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: the caravaggio study[J]. Thromb Haemost,2018,118(9):1668-1678. DOI: 10.1055/s-0038-1668523.
[20] Javaudin F, Lascarrou JB, Le Bastard Q, et al. Thrombolysis during resuscitation for out-of-hospital cardiac arrest caused by pulmonary embolism increases 30-day survival: findings from the French national cardiac arrest registry[J]. Chest, 2019,156(6):1167-1175. DOI: 10.1016/j.chest.2019.07.015.
[21] Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany[J]. Eur Heart J, 2020,41(4):522-529. DOI: 10.1093/eurheartj/ehz236.
[22] Gayou EL, Makary MS, Hughes DR, et al. Nationwide trends in use of catheter-directed therapy for treatment of pulmonary embolism in medicare beneficiaries from 2004 to 2016[J]. J Vasc Interv Radiol, 2019,30(6):801-806. DOI: 10.1016/j. jvir.2019.02.024.
[23] Piazza G, Hohlfelder B, Jaff MR, et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLEⅡ study[J]. JACC Cardiovasc Interv, 2015,8(10):1382-1392. DOI: 10.1016/j.jcin.2015.04.020.
[24] Tapson VF, Sterling K, Jones N, et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial[J]. JACC Cardiovasc Interv, 2018,11(14):1401-1410. DOI: 10.1016/j.jcin.2018.04.008.
[25] Pei DT, Liu J, Yaqoob M, et al. Meta-analysis of catheter directed ultrasound-assisted thrombolysis in pulmonary embolism[J]. Am J Cardiol,2019,124(9):1470-1477. DOI: 10.1016/j.amjcard.2019.07.040.
[26] Rothschild DP, Goldstein JA, Ciacci J, et al. Ultrasound-accelerated thrombolysis (USAT) versus standard catheter-directed thrombolysis (CDT) for treatment of pulmonary embolism: a retrospective analysis[J]. Vasc Med, 2019,24(3):234-240. DOI: 10.1177/1358863X19838350.
[27] Rao G, Xu H, Wang JJ, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute pulmonary embolism: a multicenter comparison of patient- centered outcomes[J]. Vasc Med, 2019,24(3):241-247. DOI: 10.1177/1358863X19838334.
[28] Beyer SE, Shanafelt C, Pinto DS, et al. Utilization and outcomes of thrombolytic therapy for acute pulmonary embolism: a nationwide cohort study[J]. Chest, 2020, 157(3):645-653. DOI: 10.1016/j.chest.2019.10.049.
[29] Tu T, Toma C, Tapson VF, et al. A Prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study[J]. JACC Cardiovasc Interv, 2019,12(9):859-869. DOI: 10.1016/j.jcin.2018.12.022.
[30] Kon ZN, Pasrija C, Bittle GJ, et al. The incidence and outcomes of surgical pulmonary embolectomy in north America[J]. Ann Thorac Surg, 2019,107(5):1401-1408. DOI: 10.1016/j.athoracsur.2018.10.035.
[31] O′Malley TJ, Choi JH, Maynes EJ, et al. Outcomes of extracorporeal life support for the treatment of acute massive pulmonary embolism: a systematic review[J]. Resuscitation, 2020,146:132-137. DOI: 10.1016/j.resuscitation.2019.11.018.
[32] Meneveau N, Guillon B, Planquette B, et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases[J]. Eur Heart J, 2018,39(47):4196-4204. DOI: 10.1093/eurheartj/ehy464.
[33] Provias T, Dudzinski DM, Jaff MR, et al. The massachusetts general hospital pulmonary embolism response team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism[J]. Hosp Pract,2014,42(1):31-37. DOI: 10.3810/hp.2014.02.1089.
[34] 刘冰洋 . 多学科肺栓塞应急救治团队建设的发展现状 [J]. 中国循环杂志 ,2019,34(3):305-308. DOI: 10.3969/j.issn. 1000-3614.2019.03.019.
[35] Dudzinski DM, Piazza G. Multidisciplinary pulmonary embolism response teams[J]. Circulation,2016,133(1):98-103. DOI: 10.1161/CIRCULATIONAHA.115.015086.
[36] Rosovsky R, Chang Y, Rosenfield K, et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis[J]. J Thromb Thrombolysis, 2019,47(1):31-40. DOI: 10.1007/s11239-018-1737-8.
[37] Jen WY, Kristanto W, Teo L,et al. Assessing the impact of a pulmonary embolism response team and treatment protocol on patients presenting with acute pulmonary embolism[J]. Heart Lung Circ,2020,29(3):345-353. DOI: 10.1016/j.hlc.2019.02.190.
[38] Chaudhury P, Gadre SK, Schneider E, et al. Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes[J]. Am J Cardiol, 2019,124(9):1465-1469. DOI: 10.1016/j.amjcard.2019. 07.043.